SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-140367
Filing Date
2013-04-03
Accepted
2013-04-03 16:09:11
Documents
3
Period of Report
2013-04-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d516199d8k.htm 8-K 18702
2 EX-99.1 d516199dex991.htm EX-99.1 10667
3 GRAPHIC g516199g45y80.jpg GRAPHIC 15390
  Complete submission text file 0001193125-13-140367.txt   51929
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34828 | Film No.: 13739564
SIC: 2834 Pharmaceutical Preparations